133 related articles for article (PubMed ID: 29880351)
21. Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients.
Son BS; Lee HJ; Cho WH; So MW; Park JM; Yeo HJ
Transpl Immunol; 2023 Oct; 80():101901. PubMed ID: 37442212
[TBL] [Abstract][Full Text] [Related]
22. Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.
Kang ZY; Liu C; Liu W; Li DH
Nephrol Dial Transplant; 2022 May; 37(6):1171-1180. PubMed ID: 34865146
[TBL] [Abstract][Full Text] [Related]
23. Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Deltombe C; Gillaizeau F; Anglicheau D; Morelon E; Trébern-Launay K; Le Borgne F; Rimbert M; Guérif P; Malard-Castagnet S; Foucher Y; Giral M
Transpl Int; 2017 Nov; 30(11):1150-1160. PubMed ID: 28686316
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients.
Stern R; Chen L; Chan AP; Wozniak LJ; Pearl M
Pediatr Nephrol; 2023 Dec; 38(12):4175-4185. PubMed ID: 37432534
[TBL] [Abstract][Full Text] [Related]
25. Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years.
Aziz F; Jung-Hynes B; Parajuli S; Redfield RR; Astor BC; Mandelbrot D; Hidalgo L; Djamali A
Clin Nephrol; 2020 Nov; 94(5):245-251. PubMed ID: 32870149
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
Pearl MH; Zhang Q; Palma Diaz MF; Grotts J; Rossetti M; Elashoff D; Gjertson DW; Weng P; Reed EF; Tsai Chambers E
Kidney Int; 2018 Jan; 93(1):260-269. PubMed ID: 28927645
[TBL] [Abstract][Full Text] [Related]
27. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
Fuss A; Hope CM; Deayton S; Bennett GD; Holdsworth R; Carroll RP; Coates PT
Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938
[TBL] [Abstract][Full Text] [Related]
28. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
Pearl MH; Chen L; Zuckerman JE; Weng PL; Chambers ET; Zhang Q; Reed EF
Transplantation; 2024 Jan; 108(1):276-283. PubMed ID: 37527494
[TBL] [Abstract][Full Text] [Related]
29. Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant Recipients.
Abuzeineh M; Kyeso Y; Philogene MC; Alachkar N; Alasfar S
Transplant Proc; 2021 Jun; 53(5):1501-1508. PubMed ID: 33573814
[TBL] [Abstract][Full Text] [Related]
30. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.
Pearl MH; Chen L; ElChaki R; Elashoff D; Gjertson DW; Rossetti M; Weng PL; Zhang Q; Reed EF; Chambers ET
Kidney Int Rep; 2020 Nov; 5(11):1925-1936. PubMed ID: 33163713
[TBL] [Abstract][Full Text] [Related]
31. Histopathological Relevance of Angiotensin II Type 1 Receptor in Renal Transplant Biopsy.
Sas A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Mazanowska O; Krajewska M; Chudoba P; Korta K; Hałoń A; Klinger M; Banasik M
Transplant Proc; 2018; 50(6):1847-1849. PubMed ID: 30056913
[TBL] [Abstract][Full Text] [Related]
32. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
33. The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation.
Lee J; Huh KH; Park Y; Park BG; Yang J; Jeong JC; Lee J; Park JB; Cho JH; Lee S; Ro H; Han SY; Kim MS; Kim YS; Kim SJ; Kim CD; Chung W; Park SB; Ahn C;
Nephrol Dial Transplant; 2017 Jul; 32(7):1244-1250. PubMed ID: 26546592
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.
Reinsmoen NL; Lai CH; Heidecke H; Haas M; Cao K; Ong G; Naim M; Wang Q; Mirocha J; Kahwaji J; Vo AA; Jordan SC; Dragun D
Transplantation; 2010 Dec; 90(12):1473-7. PubMed ID: 21030904
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II Type 1 Receptor Antibody-mediated Rejection Following Orthotopic Heart Transplant: A Single-center Experience.
Moreno JD; Verma AK; Kopecky BJ; Dehner C; Kostelecky N; Vader JM; Lin CY; Schilling JD
Transplantation; 2022 Feb; 106(2):373-380. PubMed ID: 33988339
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review.
Sorohan BM; Ismail G; Leca N; Tacu D; Obrișcă B; Constantinescu I; Baston C; Sinescu I
Transplant Rev (Orlando); 2020 Oct; 34(4):100573. PubMed ID: 33002671
[TBL] [Abstract][Full Text] [Related]
37. The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients.
Marian U; Slavcev A; Gazdic T; Ivak P; Netuka I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):518-523. PubMed ID: 27132810
[TBL] [Abstract][Full Text] [Related]
38. Successful Treatment of Anti-angiotensin II Type 1 Receptor Antibody-Associated Rejection in Kidney Transplantation: A Case Report.
Wiwattanathum P; Ingsathit A; Thammanichanond D; Worawichawong S
Transplant Proc; 2018 Apr; 50(3):877-880. PubMed ID: 29331505
[TBL] [Abstract][Full Text] [Related]
39. Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome.
Pinelli DF; Friedewald JJ; Haarberg KMK; Radhakrishnan SL; Zitzner JR; Hanshew WE; Tambur AR
Hum Immunol; 2017; 78(5-6):421-427. PubMed ID: 28372986
[TBL] [Abstract][Full Text] [Related]
40. Non-HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation.
Chan AP; Guerra MR; Rossetti M; Hickey MJ; Venick RS; Marcus EA; McDiarmid SV; Farmer DG; Reed EF; Wozniak LJ
Pediatr Transplant; 2021 May; 25(3):e13987. PubMed ID: 33590644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
